A neutralization assay for chikungunya virus infections in a multiplex format

Journal of Virological Methods

Volumn 201, Issue , 2014, Pages 7-12

  Weber, Christopher ^a   König, Renate ^a,b   Niedrig, Matthias ^c   Emmerich, Petra ^d   Schnierle, Barbara S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b BURNHAM INSTITUTE   (United States)

^c ROBERT KOCH INSTITUTE   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Chikungunya virus; Lentiviral vectors; Neutralization

Indexed keywords

LENTIVIRUS VECTOR; POLYETHYLENEIMINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

AEDES ALBOPICTUS; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLIMATE CHANGE; DOSE RESPONSE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PLASMID; PRIORITY JOURNAL; PSEUDOTYPING; RASH; SUPERNATANT; TISSUE CULTURE; ULTRACENTRIFUGATION; VIRAL TROPISM; VIRUS DETECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WESTERN BLOTTING; BLOOD; CELL LINE; DIAGNOSTIC USE; DRUG DEVELOPMENT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LENTIVIRINAE; PROCEDURES; SERODIAGNOSIS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; CHIKUNGUNYA VIRUS; DRUG DISCOVERY; HUMANS; LENTIVIRUS; NEUTRALIZATION TESTS; VIRAL VACCINES;

EID: 84895182339     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.02.001     Document Type: Article

References (25)

1. Agarwal S., Nikolai B., Yamaguchi T., Lech P., Somia N.V. Construction and use of retroviral vectors encoding the toxic gene barnase. Mol. Ther. 2006, 14:555-563.
2. Akahata W., Yang Z.Y., Andersen H., Sun S., Holdaway H.A., Kong W.P., Lewis M.G., Higgs S., Rossmann M.G., Rao S., Nabel G.J. A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection. Nat. Med. 2010, 16:334-338.
3. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106:761-771.
4. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7297-7301.
5. Dervillez X., Klaukien V., Durr R., Koch J., Kreutz A., Haarmann T., Stoll M., Lee D., Carlomagno T., Schnierle B., Mobius K., Konigs C., Griesinger C., Dietrich U. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage. J. Virol. 2010, 84:10131-10138.
6. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 1998, 72:8463-8471.
7. Glasker S., Lulla A., Lulla V., Couderc T., Drexler J.F., Liljestrom P., Lecuit M., Drosten C., Merits A., Kummerer B.M. Virus replicon particle based chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol. J. 2013, 10:235.
8. Kishishita N., Takeda N., Anuegoonpipat A., Anantapreecha S. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection. J. Clin. Microbiol. 2013, 51:1389-1395.
9. Kruger U., Pfeiffer T., Bosch V. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis. AIDS Res. Hum. Retroviruses 1996, 12:783-792.
10. Lusso P., Cocchi F., Balotta C., Markham P.D., Louie A., Farci P., Pal R., Gallo R.C., Reitz M.S. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 1995, 69:3712-3720.
11. Mayne J.T., Rice C.M., Strauss E.G., Hunkapiller M.W., Strauss J.H. Biochemical studies of the maturation of the small Sindbis virus glycoprotein E3. Virology 1984, 134:338-357.
12. Medlock J.M., Hansford K.M., Schaffner F., Versteirt V., Hendrickx G., Zeller H., Van B.W. A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options. Vector Borne Zoonotic Dis. 2012, 12:435-447.
13. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A.C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., Silvi G., Angelini P., Dottori M., Ciufolini M.G., Majori G.C., Cassone A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370:1840-1846.
14. Rochlin I., Ninivaggi D.V., Hutchinson M.L., Farajollahi A. Climate change and range expansion of the Asian tiger mosquito (Aedes albopictus) in Northeastern USA: implications for public health practitioners. PLoS ONE 2013, 8:e60874.
15. Salvador B., Zhou Y., Michault A., Muench M.O., Simmons G. Characterization of chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 2009, 393:33-41.
16. Schnierle B.S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8640-8645.
17. Schwartz O., Albert M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010, 8:491-500.
18. Seaman M.S., Janes H., Hawkins N., Grandpre L.E., Devoy C., Giri A., Coffey R.T., Harris L., Wood B., Daniels M.G., Bhattacharya T., Lapedes A., Polonis V.R., McCutchan F.E., Gilbert P.B., Self S.G., Korber B.T., Montefiori D.C., Mascola J.R. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 2010, 84:1439-1452.
19. Siegert S., Thaler S., Wagner R., Schnierle B.S. Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors. AIDS Res. Ther. 2005, 2:7.
20. Snyder A.J., Mukhopadhyay S. The alphavirus E3 glycoprotein functions in a clade-specific manner. J. Virol. 2012, 86:13609-13620.
21. Solignat M., Gay B., Higgs S., Briant L., Devaux C. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 2009, 393:183-197.
22. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995, 23:628-633.
23. Stitz J., Buchholz C.J., Engelstadter M., Uckert W., Bloemer U., Schmitt I., Cichutek K. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 2000, 273:16-20.
24. Thiboutot M.M., Kannan S., Kawalekar O.U., Shedlock D.J., Khan A.S., Sarangan G., Srikanth P., Weiner D.B., Muthumani K. Chikungunya: a potentially emerging epidemic?. PLoS Negl. Trop. Dis. 2010, 4:e623.
25. Voss J.E., Vaney M.C., Duquerroy S., Vonrhein C., Girard-Blanc C., Crublet E., Thompson A., Bricogne G., Rey F.A. Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography. Nature 2010, 468:709-712.